You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
of respondents reported having asthma, 13% have COPD
of PI patients reported they suffer from chronic lung conditions
of PI patients report lung infections and other infections in the prior 12 months
of PI patients reported being hospitalized in the prior 12 months due to lung impairments
One infection is one too many! Each time a PI patient gets a serious infection, irreparable damage occurs.
1. McCusker C, Upton J, Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol. 2018;14(suppl 2):61. doi:10.1186/s13223-018-029